توقعات سوق تجزئة البلازما في الشرق الأوسط وأفريقيا حتى عام 2028 - تأثير فيروس كورونا (COVID-19) والتحليل الإقليمي حسب المنتج (الجلوبيولين المناعي، الزلال، مركزات عامل التخثر، مثبطات الأنزيم البروتيني، ومنتجات البلازما الأخرى)، التطبيق (علم الأعصاب، علم المناعة، أمراض الدم، الرعاية الحرجة، أمراض الرئة) والتطبيقات الأخرى)، والمستخدم النهائي (المستشفيات والعيادات، ومختبرات الأبحاث السريرية، والمعاهد الأكاديمية)

TABLE OF CONTENTS

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Plasma Fractionation Market – By Product

1.3.2        MEA Plasma Fractionation Market – By Application

1.3.3        MEA Plasma Fractionation Market – By End User

1.3.4        MEA Plasma Fractionation Market – By Country

2.           MEA Plasma Fractionation Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Plasma Fractionation Market – Market Landscape

4.1         Overview

4.2         MEA PEST Analysis

4.3         Experts Opinion

5.           MEA Plasma Fractionation Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Plasma Therapy Getting Popular

5.1.2        Significant Rise in Participation of the Players in Market Developments

5.2         Market Restraints

5.2.1        Various Non-Plasma Substitutes Available

5.3         Market Opportunities

5.3.1        Emerging Countries Showing Development Capability

5.4         Future Trends

5.4.1        Plasma Therapy in the Treatment of Novel Diseases

5.5         Impact Analysis

6.           Plasma Fractionation Market – MEA Analysis

6.1         MEA Plasma Fractionation Market Revenue Forecast and Analysis

7.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028– by Product

7.1         Overview

7.2         MEA Plasma Fractionation Market, By Product 2021 & 2028 (%)

7.3         Immunoglobulin

7.3.1        Overview

7.3.2        Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.1          Intravenous Immunoglobulin (IVIG)

7.3.2.1.1          Overview

7.3.2.1.2          Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.3.2.2          Subcutaneous Immunoglobulin (SCIG)

7.3.2.2.1          Overview

7.3.2.2.2          Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Albumin

7.4.1        Overview

7.4.2        Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Coagulation Factor Concentrates

7.5.1        Overview

7.5.2        Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Protease Inhibitors

7.6.1        Overview

7.6.2        Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Other Plasma Products

7.7.1        Overview

7.7.2        Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

8.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028 – Application

8.1         Overview

8.2         MEA Plasma Fractionation Market Share by Application 2021 & 2028 (%)

8.3         Neurology

8.3.1        Overview

8.3.2        Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.4         Immunology

8.4.1        Overview

8.4.2        Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.5         Hematology

8.5.1        Overview

8.5.2        Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.6         Critical Care

8.6.1        Overview

8.6.2        Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.7         Pulmonology

8.7.1        Overview

8.7.2        Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

8.8         Other Applications

8.8.1        Overview

8.8.2        Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.           MEA Plasma Fractionation Market Revenue and Forecasts To 2028 – End User

9.1         Overview

9.2         MEA Plasma Fractionation Market Share by End User 2021 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.4         Clinical Research Laboratories

9.4.1        Overview

9.4.2        Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

9.5         Academic Institutes

9.5.1        Overview

9.5.2        Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)

10.        MEA Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis

10.1      Overview

10.1.1     MEA Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1       UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1       Overview

10.1.1.1.2       UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.3       UAE: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3.1    UAE: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.1.4       UAE: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.1.4.1    UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.2       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1       Overview

10.1.1.2.2       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.3       Saudi Arabia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3.1    Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.2.4       Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.2.5       Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.3       South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1       Overview

10.1.1.3.2       South Africa Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.3       South Africa: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3.1    South Africa: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.3.4       South Africa: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.3.4.1    South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

10.1.1.4       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1       Overview

10.1.1.4.2       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.3       Rest of MEA: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3.1    Rest of MEA: Plasma Fractionation Market, by Immunoglobulin Type, 2019–2028 (USD Million)

10.1.1.4.4       Rest of MEA: Plasma Fractionation Market Revenue and Forecasts To 2028, By Application (US$ Mn)

10.1.1.4.5       Rest of MEA: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

11.        Impact Of COVID-19 Pandemic on MEA Plasma Fractionation Market

11.1      MEA: Impact Assessment of COVID-19 Pandemic

12.        Plasma Fractionation Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Followed by Major Market Players (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic developments

12.4.1     Overview

13.        Company Profiles

13.1      Biotest AG.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Octapharma AG

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Kedrion S.p.A

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      CSL Limited

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Grifols, S.A.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Bio Products Laboratory Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Bharat Serums and Vaccines Limited (BSV)

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      SK Plasma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             UAE: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 2.             UAE: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             UAE: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.             UAE: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 5.             Saudi Arabia: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 6.             Saudi Arabia: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 7.             Saudi Arabia: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.             Saudi Arabia: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 9.             South Africa Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 10.          South Africa: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          South Africa: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          South Africa: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 13.          Rest of MEA: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 14.          Rest of MEA: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)

Table 15.          Rest of MEA: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Rest of MEA: Plasma Fractionation Market, By End User – Revenue and Forecast to 2028 (USD Million)

Table 17.          Organic Developments Done By Companies

Table 18.          Inorganic developments done by Companies

Table 19.          Glossary of Terms, MEA Plasma Fractionation Market

LIST OF FIGURES

Figure 1.           MEA Plasma Fractionation Market Segmentation

Figure 2.           MEA Plasma Fractionation Market Segmentation, By Country

Figure 3.           MEA Plasma Fractionation Market Overview

Figure 4.           Immunoglobulin Segment Held the Largest Share of the Product Segment in MEA Plasma Fractionation Market

Figure 5.           Saudi Arabia to Show Significant Growth During Forecast Period

Figure 6.           MEA PEST Analysis

Figure 7.           Impact Analysis of Drivers and Restraints Pertaining to MEA Plasma Fractionation Market

Figure 8.           MEA Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028

Figure 9.           MEA Plasma Fractionation Market, by Product 2021 & 2028 (%)

Figure 10.        MEA Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        MEA Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        MEA Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        MEA Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        MEA Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        MEA Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)

Figure 16.        MEA Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        MEA Plasma Fractionation Market Share by Application 2021 & 2028 (%)

Figure 18.        MEA Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 19.        MEA Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 20.        MEA Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 21.        MEA Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 22.        MEA Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 23.        MEA Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 24.        MEA Plasma Fractionation Market Share by End User 2021 & 2028 (%)

Figure 25.        MEA Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 26.        MEA Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 27.        MEA Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)

Figure 28.        MEA Plasma Fractionation Market Revenue Overview, by Country, 2021 (US$ Mn)

Figure 29.        MEA Plasma Fractionation Market Revenue and Forecasts to 2028, By Country (%)

Figure 30.        UAE: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        Saudi Arabia: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        South Africa: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        Rest of MEA: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.        Impact of COVID-19 Pandemic in MEA Country Markets

Figure 35.        Growth Strategies Followed by Major Market Players (%)

1. Bharat Serums and Vaccines Limited (BSV)
2. Bio Products Laboratory Ltd.
3. Biotest AG.
4. CSL Limited
5. Grifols, S.A.
6. Kedrion S.p.A
7. Octapharma AG
8. SK Plasma

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the MEA plasma fractionation market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the MEA plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth MEA market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution